Additional Proxy Soliciting Materials (definitive) (defa14a)
July 14 2020 - 04:06PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment
No.
)
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
|
Preliminary Proxy Statement
|
☐
|
Confidential, for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2))
|
☐
|
Definitive Proxy Statement
|
☒
|
Definitive Additional Materials
|
☐
|
Soliciting Material under §240.14a-12
|
ACORDA THERAPEUTICS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the
Registrant)
Payment of Filing Fee (Check the appropriate box):
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1)
and 0-11.
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
(3)
|
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on
which the filing fee is calculated and state how it was
determined):
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
☐
|
Fee paid previously with preliminary materials.
|
☐
|
Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date
of its filing.
|
|
(1)
|
Amount Previously Paid:
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|

July 14, 2020
Dear Stockholder:
We have previously sent you proxy material for the Special Meeting
of Stockholders of Acorda Therapeutics, Inc. taking place on July
31, 2020. Your Board of Directors
unanimously recommends that stockholders vote FOR all of the
proposals on the agenda.
Approval of the Authorized Common Stock Increase Proposal and the
Reverse Stock Split Proposal requires the affirmative vote of a
majority of the outstanding shares. THEREFORE, YOUR VOTE IS VERY IMPORTANT.
To ensure your shares are represented at the Special Meeting,
please vote
TODAY--via the
Internet or by telephone using the enclosed instructions, or
alternatively by signing, dating and returning the enclosed voting
instruction form or proxy card in the postage-paid envelope
provided.
Thank you for your cooperation.
Very truly yours,
Andrew Mayer
Deputy General Counsel and Corporate Secretary
|
REMEMBER:
You can vote your shares via the Internet or by telephone or
alternatively by signing, dating and returning the enclosed voting
instruction form or proxy card.
Please simply follow the easy instructions on the enclosed voting
instruction form or proxy card to cast your vote.
If you have any questions, or need assistance in voting
your shares, please call our proxy solicitor:
INNISFREE M&A INCORPORATED
TOLL-FREE, at 1-877-717-3929
|
Acorda Therapeutics (NASDAQ:ACOR)
Historical Stock Chart
From Dec 2020 to Jan 2021
Acorda Therapeutics (NASDAQ:ACOR)
Historical Stock Chart
From Jan 2020 to Jan 2021